When Albumin Meets Liposomes: A Feasible Drug Carrier for Biomedical Applications
Albumin, the most abundant protein in plasma, possesses some inherent beneficial structural and physiological characteristics that make it suitable for use as a drug delivery agent, such as an extraordinary drug-binding capacity and long blood retention, with a high biocompatibility. The use of thes...
Main Authors: | Kazuaki Taguchi, Yuko Okamoto, Kazuaki Matsumoto, Masaki Otagiri, Victor Tuan Giam Chuang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/4/296 |
Similar Items
-
The Therapeutic Effect of Human Serum Albumin Dimer-Doxorubicin Complex against Human Pancreatic Tumors
by: Ryo Kinoshita, et al.
Published: (2021-08-01) -
Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen Carriers
by: Kazuaki Taguchi, et al.
Published: (2017-03-01) -
Evaluation of the Effect of Liposome Carriers and Albumin Nanoparticles Containing Activated Melittin on Inhibiting the Growth of Leishmania Major Amastigote in vivo
by: Soheila Akhzari, et al.
Published: (2021-12-01) -
Liposomal Artificial Red Blood Cell-Based Carbon Monoxide Donor Is a Potent Renoprotectant against Cisplatin-Induced Acute Kidney Injury
by: Kazuaki Taguchi, et al.
Published: (2021-12-01) -
Metal-catalyzed oxidation of human serum albumin does not alter the interactive binding to the two principal drug binding sites
by: Keishi Yamasaki, et al.
Published: (2018-07-01)